Keyphrases
Orthotopic Model
100%
Small Animal Positron Emission Tomography
100%
Treatment Response
100%
Anti-VEGF Therapy
100%
Glioblastoma
100%
Tyrosine
100%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
55%
Positron Emission Tomography
44%
Microvessel Density
22%
Bioluminescence Imaging
22%
Ki-67 Index
22%
Mean Survival Time
11%
Tracer Uptake
11%
Early Predictors
11%
MRI Brain Tumor
11%
Positron Emission tomography-CT
11%
SUVmax Values
11%
Treatment Group
11%
Xenograft
11%
Tumor-to-background Ratio
11%
Thymidine
11%
Thymidine Analogs
11%
Early Response
11%
No Significant Difference
11%
Treatment Initiation
11%
Fluorothymidine
11%
Patient Care
11%
Medicine and Dentistry
Glioblastoma
100%
positron emission tomographic scan
100%
Treatment Response
100%
Vasculotropin
100%
Microvessel
25%
Bioluminescence
25%
Xenograft
25%
Radioactive Tracer
25%
Neoplasm
12%
Clinical Study
12%
Intracranial Tumor
12%
Patient Care
12%
Survival Time
12%
Amino Acid
12%
Tumor Imaging
12%
Thymidine
12%
Treatment Group
12%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Glioblastoma
100%
Tracer
25%
Clinical Study
12%
Survival Time
12%
Treatment Group
12%
Intracranial Tumor
12%
Neoplasm
12%
Thymidine
12%
Amino Acid
12%
Neuroscience
Vascular Endothelial Growth Factor
100%
positron emission tomographic scan
100%
Bioluminescence
25%
Microvessel
25%
Thymidine
12%
Amino Acid
12%
Intracranial Tumor
12%